Uber Technologies, Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 2, 2022 and accepted by EDGAR at Nov 2, 2022, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $8.34bn | us-gaap:Revenues |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $23.27bn | us-gaap:Revenues |
| Research and development | 3 months2022-07-01 to 2022-09-30 | $760.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-01-01 to 2022-09-30 | $2.05bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-07-01 to 2022-09-30 | −$495.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | −$1.69bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-07-01 to 2022-09-30 | $146.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-01-01 to 2022-09-30 | $414.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $58.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | −$97.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | −$1.21bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | −$9.74bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-07-01 to 2022-09-30 | −$0.61 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-01 to 2022-09-30 | −$4.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | −$0.61 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | −$4.96 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 1,979,299,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 1,968,228,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | $886.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $193.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-09-30 | $4.87bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $9.37bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $31.11bn | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $9.02bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $23.71bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-09-30 | $9.27bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-09-30 | $27.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-09-30 | $6.25bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001543151-22-000034. Last ingested by Listed: Nov 4, 2026, 17:04 ET. Listed shows no prices and gives no investment advice.